Flagship Pioneering is a biotechnology innovation company based in Cambridge, Massachusetts, that invents and builds platform companies with the potential to transform human health and sustainability. Since its inception in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in over $60 billion in aggregate value. The firm operates with $14 billion in assets under management as of its latest capital raise in July 2024.

Flagship's portfolio includes over 40 companies, such as Moderna, Generate Biomedicines, Inari Agriculture, and Tessera Therapeutics. The company's investment strategy focuses on developing platform companies that can generate multiple products addressing significant global challenges, including disease prevention and treatment, sustainable agriculture, and climate change mitigation. Flagship's approach combines life science innovation, capital formation, company formation, and scaling in a way that is largely without precedent.

Notably, Flagship was recognized as the #3 most innovative company in North America in Fast Company's 2024 list of the World's Most Innovative Companies, marking the third consecutive year the firm has been included.